San Diego Union-Tribune - Its sales were led by Singulair for asthma and allergies, at $1 billion; osteoporosis treatment Fosamax, with $725 million in sales; blood pressure medicines Cozaar and Hyzaar, at $814 million; and several vaccines with combined sales of $1.2 billion ...
